In her recent newsletter issue (eHIV Review V5 #1), Dr. Ethel Weld, Assistant Professor of Medicine, Pharmacology and Molecular Sciences at the Johns Hopkins School of Medicine, analyzed the current research about the potential uses of two-drug ART regimens. Join her now for a case-based discussion about how that new information can affect patient selection in the clinic.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
Podcast (ehiv): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS